Functional Electrical Stimulation for People With Multiple Sclerosis Who Experience Foot Drop
Launched by QUEEN MARGARET UNIVERSITY · Jul 31, 2013
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Participants People with MS (aged 18 or over) who are assessed for their suitability for FES to treat foot-drop at Slateford Medical Centre are eligible for participation in this study.
For this feasibility study we aim to recruit at least 10 participants.
Recruitment Eligible patients will be given an information sheet by their physiotherapist who will introduce the study at their initial appointment. A second appointment is made to fit the FES unit and if the patient is willing to consider taking part in the study, informed consent is taken.
Data collection To record the degree of foot...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • People with MS (aged 18-80) who are assessed for their suitability for FES to treat foot-drop between September 2013 and March 2014 at Slateford Medical Centre are eligible for participation in this study
- Exclusion Criteria:
- • Patients with fixed ankle deformities, who are allergic to tape and who are unable to walk for at least for two minutes (with or without walking aids) will be excluded.
- • Patients who experienced a relapse or any trauma affecting their walking between the first fitting appointment and the follow-up appointment will also be excluded from the study.
About Queen Margaret University
Queen Margaret University (QMU) is a renowned institution dedicated to advancing health and social care through innovative research and academic excellence. With a strong emphasis on interdisciplinary collaboration, QMU engages in clinical trials that aim to enhance patient outcomes and inform evidence-based practices. The university’s commitment to addressing real-world health challenges is reflected in its partnerships with healthcare providers and stakeholders, ensuring that research findings translate effectively into practice. Through its robust ethical standards and focus on participant welfare, QMU is poised to contribute significantly to the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edinburgh, , United Kingdom
Patients applied
Trial Officials
Marietta L van der Linden, PhD
Principal Investigator
Queen Margaret University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials